Hongjun Gao

2.1k total citations
72 papers, 1.1k citations indexed

About

Hongjun Gao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hongjun Gao has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Hongjun Gao's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (18 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Hongjun Gao is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (18 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Hongjun Gao collaborates with scholars based in China, United States and Taiwan. Hongjun Gao's co-authors include Haifeng Qin, Xue Du, Yanhong Tai, Yun Shao, Chuanhao Tang, Shaoxing Yang, Xiaoqing Liu, Yi Liu, Haixu Hu and Lili Qu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hongjun Gao

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongjun Gao China	19	557	478	449	348	107	72	1.1k
Yuxi Zhu China	17	304 0.5×	492 1.0×	197 0.4×	479 1.4×	99 0.9×	45	965
Zhenfa Zhang China	20	411 0.7×	461 1.0×	464 1.0×	319 0.9×	40 0.4×	90	1.2k
Zhenxiang Li China	18	477 0.9×	320 0.7×	281 0.6×	226 0.6×	38 0.4×	72	962
Edik M. Blais United States	16	681 1.2×	378 0.8×	180 0.4×	499 1.4×	121 1.1×	34	1.1k
Shejuan An China	16	601 1.1×	808 1.7×	722 1.6×	400 1.1×	69 0.6×	35	1.5k
Federica Biello Italy	20	634 1.1×	267 0.6×	418 0.9×	292 0.8×	37 0.3×	56	994
Isabelle Valo France	16	381 0.7×	311 0.7×	462 1.0×	211 0.6×	50 0.5×	34	1.0k
Ken Suzawa Japan	19	504 0.9×	483 1.0×	565 1.3×	282 0.8×	35 0.3×	80	1.1k
Puay Hoon Tan Singapore	18	484 0.9×	597 1.2×	461 1.0×	361 1.0×	95 0.9×	41	1.4k

Countries citing papers authored by Hongjun Gao

Since Specialization

Citations

This map shows the geographic impact of Hongjun Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjun Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjun Gao more than expected).

Fields of papers citing papers by Hongjun Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjun Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjun Gao. The network helps show where Hongjun Gao may publish in the future.

Co-authorship network of co-authors of Hongjun Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjun Gao. A scholar is included among the top collaborators of Hongjun Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjun Gao. Hongjun Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Minhua, et al.. (2025). Bibliometric study and visual analysis of postoperative diabetes mellitus in kidney transplant recipients based on WoSCC database. Renal Failure. 47(1). 2444383–2444383.

Wu, Lin, Yinghua Ji, Gongyan Chen, et al.. (2025). Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial. The Lancet Respiratory Medicine. 13(8). 677–686. 2 indexed citations

Zhou, Bingpeng, Hongjun Gao, Zhiqiang Wei, et al.. (2025). Self-Interference-Alleviated Multi-Beam Steering for On-Demand Sensing and Communication Performance Tradeoff of Full-Duplex ISAC. IEEE Transactions on Wireless Communications. 25. 177–194. 1 indexed citations

Wang, Jian, et al.. (2024). Single-centre retrospective analysis: 16 cases of percutaneous nephrolithotripsy complicating hepatic puncture injury in a 7-year experience. International Urology and Nephrology. 57(2). 383–389. 2 indexed citations

Guo, Hui, et al.. (2024). Physiological traits, gene expression responses, and proteomics of rice varieties varying in heat stress tolerance at the flowering stage. Frontiers in Plant Science. 15. 1489331–1489331. 1 indexed citations

Chen, Runsheng, et al.. (2024). P-685 An artificial intelligence based medication regimen recommendation model for optimizing the treatment outcomes of controlled ovarian stimulation. Human Reproduction. 39(Supplement_1).

Cheng, Ying, James C. Yang, Isamu Okamoto, et al.. (2023). Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia. Immunotherapy. 15(13). 1029–1044. 3 indexed citations

Yang, Shaoxing, Jing Xu, Panpan Lv, et al.. (2022). Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase‐positive non–small cell lung cancer. Thoracic Cancer. 13(12). 1788–1794. 3 indexed citations

Su, Ting‐Shi, et al.. (2020). Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy. Journal of Cancer. 11(22). 6642–6652. 7 indexed citations

10.

Li, Jinglin, et al.. (2019). Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report. Frontiers in Oncology. 9. 1360–1360. 12 indexed citations

11.

Lv, Panpan, Shaoxing Yang, Wenjing Liu, et al.. (2019). Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor‐tyrosine kinase inhibitor therapy. Thoracic Cancer. 11(1). 29–40. 19 indexed citations

12.

Qin, Haifeng, Fang Wang, Ke Wang, et al.. (2019). Aprepitant for gefitinib-induced refractory pruritus in Chinese malignancy population. Annals of Translational Medicine. 7(3). 54–54. 3 indexed citations

13.

Sun, Yulin, Hongjun Gao, Xin Zheng, et al.. (2018). miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features. Cancer Research. 79(5). 941–953. 69 indexed citations

14.

Ye, Mingxiang, Yong Zhang, Hongjun Gao, et al.. (2017). Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling. Clinical Cancer Research. 24(5). 1227–1239. 59 indexed citations

15.

Xu, Jing, Bin Xu, Chuanhao Tang, et al.. (2017). The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Disease Markers. 2017. 1–9. 10 indexed citations

16.

Yang, Lin, Chuanhao Tang, Bin Xu, et al.. (2015). Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer. PLoS ONE. 10(6). e0128970–e0128970. 8 indexed citations

17.

Tang, Chuanhao, Hongjun Gao, Xiaoyan Li, et al.. (2014). Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 140(3). 427–433. 9 indexed citations

18.

Qin, Haifeng, Lili Qu, Hui Liu, Shasha Wang, & Hongjun Gao. (2013). Serum CEA Level Change and Its Significance Before and after Gefitinib Therapy on Patients with Advanced Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention. 14(7). 4205–4208. 15 indexed citations

19.

Gao, Hongjun, et al.. (2012). Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. International Journal of Molecular Medicine. 30(5). 1061–1068. 5 indexed citations

20.

Gao, Hongjun, et al.. (2012). Identification and expression of a tumor-associated antigen in esophageal squamous cell carcinoma.. PubMed. 34(3). 244–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact